Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
02 05 2022
Historique:
received: 25 03 2021
accepted: 16 03 2022
pubmed: 23 3 2022
medline: 4 5 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

People living with HIV (PLWH) who are immune nonresponders (INRs) are at greater risk of comorbidity and mortality than are immune responders (IRs) who restore their CD4+ T cell count after antiretroviral therapy (ART). INRs have low CD4+ T cell counts (<350 c/μL), heightened systemic inflammation, and increased CD4+ T cell cycling (Ki67+). Here, we report the findings that memory CD4+ T cells and plasma samples of INRs from several cohorts are enriched in gut-derived bacterial solutes p-cresol sulfate (PCS) and indoxyl sulfate (IS) that both negatively correlated with CD4+ T cell counts. In vitro PCS or IS blocked CD4+ T cell proliferation, induced apoptosis, and diminished the expression of mitochondrial proteins. Electron microscopy imaging revealed perturbations of mitochondrial networks similar to those found in INRs following incubation of healthy memory CD4+ T cells with PCS. Using bacterial 16S rDNA, INR stool samples were found enriched in proteolytic bacterial genera that metabolize tyrosine and phenylalanine to produce PCS. We propose that toxic solutes from the gut bacterial flora may impair CD4+ T cell recovery during ART and may contribute to CD4+ T cell lymphopenia characteristic of INRs.

Identifiants

pubmed: 35316209
pii: 149571
doi: 10.1172/JCI149571
pmc: PMC9057623
doi:
pii:

Substances chimiques

Bacterial Toxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI145289
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141846
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG062386
Pays : United States

Références

Toxicol Lett. 2016 Nov 30;263:1-5
pubmed: 27760375
Sci Transl Med. 2013 Jul 10;5(193):193ra91
pubmed: 23843452
Am J Kidney Dis. 2009 Nov;54(5):891-901
pubmed: 19615803
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
Clin Infect Dis. 2005 Jun 1;40(11):1559-85
pubmed: 15889353
Toxins (Basel). 2017 Jan 29;9(2):
pubmed: 28146081
PLoS Med. 2008 Oct 21;5(10):e203
pubmed: 18942885
Nutrients. 2021 Mar 30;13(4):
pubmed: 33808476
Nat Metab. 2021 Feb;3(2):274-286
pubmed: 33619379
Adv Immunol. 2013;119:51-83
pubmed: 23886064
PLoS One. 2015 Sep 16;10(9):e0137200
pubmed: 26376436
Nephrol Dial Transplant. 2007 Feb;22(2):592-6
pubmed: 17040995
Nat Rev Genet. 2015 Sep;16(9):530-42
pubmed: 26281784
J Clin Med. 2019 Sep 10;8(9):
pubmed: 31510015
Clin Exp Nephrol. 2019 Nov;23(11):1272-1279
pubmed: 31327092
J Infect Dis. 2011 Mar 15;203(6):780-90
pubmed: 21252259
Clin Infect Dis. 2005 Aug 1;41(3):361-72
pubmed: 16007534
Microbiome. 2013 Oct 12;1(1):26
pubmed: 24451087
Clin Infect Dis. 2007 Feb 1;44(3):441-6
pubmed: 17205456
Anal Chem. 2020 Jul 7;92(13):8836-8844
pubmed: 32490663
Nat Biotechnol. 2019 Oct;37(10):1217-1228
pubmed: 31477923
Anal Bioanal Chem. 2013 Feb;405(6):1937-47
pubmed: 23307120
AIDS. 2010 Aug 24;24(13):1991-2000
pubmed: 20651586
J Infect Dis. 2015 Jan 1;211(1):19-27
pubmed: 25057045
Immunol Cell Biol. 2015 Jan;93(1):3-10
pubmed: 25267485
J Infect Dis. 2009 Apr 15;199(8):1177-85
pubmed: 19265479
Clin Infect Dis. 2009 Feb 1;48(3):350-61
pubmed: 19123865
J Clin Invest. 2018 Nov 1;128(11):5083-5094
pubmed: 30320604
PLoS Pathog. 2014 Feb 20;10(2):e1003829
pubmed: 24586144
J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):72-7
pubmed: 17621240
Cell Host Microbe. 2013 Sep 11;14(3):329-39
pubmed: 24034618
Ultrastruct Pathol. 2014 May;38(3):204-10
pubmed: 24579828
Nat Immunol. 2017 Apr 18;18(5):488-498
pubmed: 28418387
Toxins (Basel). 2018 Jun 02;10(6):
pubmed: 29865226
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Front Immunol. 2021 Dec 24;12:757935
pubmed: 35003070
J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):483-92
pubmed: 26627102
J Infect Dis. 2011 Oct 15;204(8):1217-26
pubmed: 21917895
J Electron Microsc (Tokyo). 1986;35(3):304-6
pubmed: 2440973
Toxicol Appl Pharmacol. 2014 Jan 15;274(2):191-9
pubmed: 24161588
Kidney Int. 2013 Sep;84(3):585-90
pubmed: 23636170
Mucosal Immunol. 2015 Sep;8(5):1009-20
pubmed: 25586559
AIDS. 2016 Aug 24;30(13):2033-42
pubmed: 27191978
Sci Rep. 2018 Sep 24;8(1):14277
pubmed: 30250162
Eur Heart J. 2010 Jul;31(14):1771-9
pubmed: 20047993
Ultrastruct Pathol. 2014 Feb;38(1):13-25
pubmed: 24134831
Clin Infect Dis. 2009 Mar 15;48(6):787-94
pubmed: 19193107
J Pharmacol Exp Ther. 2008 Feb;324(2):558-67
pubmed: 18042828
Clin Exp Nephrol. 2014 Oct;18(5):814-20
pubmed: 24185403
J Am Heart Assoc. 2015 Jun 11;4(6):e001852
pubmed: 26066032
Gut Microbes. 2017 Sep 3;8(5):440-450
pubmed: 28541799
J Infect Dis. 2014 Aug 15;210(4):619-29
pubmed: 24585897
AIDS. 2008 Apr 23;22(7):841-8
pubmed: 18427202
Toxins (Basel). 2015 Sep 28;7(10):3933-46
pubmed: 26426048
Nat Commun. 2021 Feb 18;12(1):1139
pubmed: 33602945
Cell. 2016 Jun 30;166(1):63-76
pubmed: 27293185
Clin Chim Acta. 2013 Apr 18;419:122-6
pubmed: 23428591
Curr Opin HIV AIDS. 2016 Mar;11(2):182-90
pubmed: 26679414
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447
Nat Commun. 2017 Sep 5;8(1):427
pubmed: 28874664
Medicine (Baltimore). 2019 Oct;98(42):e17528
pubmed: 31626113
AIDS. 2006 Oct 24;20(16):2033-41
pubmed: 17053349
Anat Rec (Hoboken). 2012 Sep;295(9):1455-61
pubmed: 22753088
Toxicol Lett. 2016 Mar 14;245:24-30
pubmed: 26784855
J Infect Dis. 2015 Mar 1;211(5):780-90
pubmed: 25214516
J Infect Dis. 2009 Sep 15;200(6):973-83
pubmed: 19678756
BMC Infect Dis. 2010 Nov 02;10:318
pubmed: 21044307
Antivir Ther. 2006;11(6):803-11
pubmed: 17310825
Open Forum Infect Dis. 2021 Dec 07;8(12):ofab550
pubmed: 34888397
Arch Toxicol. 2013 Jul;87(7):1157-80
pubmed: 23543009
Nat Rev Gastroenterol Hepatol. 2012 Sep 04;9(10):577-89
pubmed: 22945443
Toxicol Appl Pharmacol. 2018 Mar 1;342:50-59
pubmed: 29407365
J Exp Med. 2019 Jan 7;216(1):20-40
pubmed: 30322864
Oncotarget. 2017 Sep 8;8(44):77722-77733
pubmed: 29100420
Science. 2019 Dec 20;366(6472):1445-1446
pubmed: 31857466
Front Cell Dev Biol. 2020 Jun 24;8:467
pubmed: 32671064
J Bras Nefrol. 2019 Jan-Mar;41(1):48-54
pubmed: 30010693
Kidney Blood Press Res. 2014;39(2-3):114-23
pubmed: 25117687
Methods Mol Biol. 2021;2325:215-227
pubmed: 34053061
J Clin Immunol. 2005 Mar;25(2):106-15
pubmed: 15821887
Mucosal Immunol. 2014 Jul;7(4):983-94
pubmed: 24399150
Pathog Immun. 2019 Sep 23;4(2):235-250
pubmed: 31583331
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Cell. 2021 Jul 22;184(15):3899-3914.e16
pubmed: 34237254
Kidney Int. 2013 Apr;83(4):582-92
pubmed: 23325087
J Virol. 2014 May;88(10):5369-80
pubmed: 24522925
PLoS Pathog. 2021 Aug 27;17(8):e1009825
pubmed: 34449812
AIDS. 2012 Sep 24;26(15):1907-15
pubmed: 22824630
Clin J Am Soc Nephrol. 2012 Jun;7(6):982-8
pubmed: 22490877
Front Microbiol. 2018 Jul 02;9:1451
pubmed: 30034377

Auteurs

Brian Ferrari (B)

Department of Medicine, Division of Infectious Diseases and HIV Medicine, Center for AIDS Research, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Amanda Cabral Da Silva (AC)

Department of Pathology, Pathology Advanced Translational Research (PATRU), School of Medicine and.

Ken H Liu (KH)

Clinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, Georgia, USA.

Evgeniya V Saidakova (EV)

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center Ural Branch Russian Academy of Sciences, Perm, Russia.
Department of Microbiology and Immunology, Perm State University, Perm, Russia.

Larisa B Korolevskaya (LB)

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center Ural Branch Russian Academy of Sciences, Perm, Russia.

Konstantin V Shmagel (KV)

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center Ural Branch Russian Academy of Sciences, Perm, Russia.

Carey Shive (C)

Department of Medicine, Division of Infectious Diseases and HIV Medicine, Center for AIDS Research, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Cleveland VA Medical Center, Cleveland, Ohio, USA.

Gabriela Pacheco Sanchez (G)

Department of Pathology, Pathology Advanced Translational Research (PATRU), School of Medicine and.

Mauricio Retuerto (M)

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center Ural Branch Russian Academy of Sciences, Perm, Russia.

Ashish Arunkumar Sharma (AA)

Department of Microbiology and Immunology, Perm State University, Perm, Russia.

Khader Ghneim (K)

Department of Microbiology and Immunology, Perm State University, Perm, Russia.

Laura Noel-Romas (L)

Integrated Microbiome Core, Department of Dermatology, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, Ohio, USA.
Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.

Benigno Rodriguez (B)

Department of Medicine, Division of Infectious Diseases and HIV Medicine, Center for AIDS Research, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Mahmoud A Ghannoum (MA)

Integrated Microbiome Core, Department of Dermatology, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, Ohio, USA.

Peter P Hunt (PP)

Department of Medicine, UCSF, San Francisco, California, USA.

Steven G Deeks (SG)

Department of Medicine, UCSF, San Francisco, California, USA.

Adam D Burgener (AD)

Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.
Department of Obstetrics & Gynecology, University of Manitoba, Winnipeg, Manitoba, Canada.

Dean P Jones (DP)

Clinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, Georgia, USA.

Mirela A Dobre (MA)

Department of Medicine (Nephrology), Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Vincent C Marconi (VC)

Division of Infectious Diseases, Department of Global Health, and Department of Global Health, Rollins School of Public Health, Atlanta, Georgia, USA.

Rafick-Pierre Sekaly (RP)

Department of Pathology, Pathology Advanced Translational Research (PATRU), School of Medicine and.

Souheil-Antoine Younes (SA)

Department of Pathology, Pathology Advanced Translational Research (PATRU), School of Medicine and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH